
NANOTEMPER TECHNOLOGIES, INC.
At NanoTemper, we have one clear goal: a world where every disease is treatable.
This vision prompts us to empower scientists with biophysical solutions they trust, helping them discover life-saving therapies—even the toughest ones.
As a 100% founder-owned company, we are driven by a vision to continuously pioneer groundbreaking ideas, redefine what’s possible, and push boundaries. Innovation is in our DNA, driving our commitment to precision, uncompromising quality, and strong, collaborative partnerships with our customers.
That’s why we develop the highest-quality instruments, delivering reliable and precise results. Made to be easy-to-learn, easy-to-use, and automation-ready, our solutions streamline workflows while increasing efficiency. We support our customers with in-depth knowledge and scientific expertise at every stage of their journey, ensuring they achieve their goals.
Since 2008, leading pharmaceutical companies, biotech firms, and research institutions have relied on our solutions to accelerate drug development. And this was just our beginning: we’re advancing into biomanufacturing with end-to-end, GMP-compliant solutions supporting the entire drug development process—from discovery to release.
CONTACT INFORMATION
NanoTemper Technologies, Inc.
400 Oyster Point Blvd. Suite 336
South San Francisco, CA 94080
UNITED STATES
Contact: Léa Valla
E-BOOK
-
Optimize your lab's purchasing decisions for binding affinity solutions. Learn to quantify binding affinity, understand its significance in biological processes, and explore the tools available to advance your research.
FEATURED ARTICLES
-
Overcoming the limitations of current proximity inducers requires optimizing cooperativity. Learn how enhancing target affinity can lead to smaller, more effective therapeutics with better safety profiles.
-
Maximize your research potential by overcoming workflow bottlenecks. This piece explores flexible strategies for increasing throughput and integrating automation seamlessly into your laboratory operations.
-
Technological advancements are driving significant change in biomanufacturing. An industry expert highlights three pivotal areas: data science, advanced automation, and process analytical technologies.
-
Gain valuable perspectives on the future of biomanufacturing, including the impact of data science, automation, and continuous learning, shared by an experienced biophysics specialist in the field.
-
Discover how the biotinylated target labeling kit enables efficient screening and validation of challenging targets using spectral Shift and SPR technologies in your drug discovery process.
-
Mark your calendar for these five pivotal biologics conferences in 2025, offering a unique blend of scientific insights, networking, and glimpses into the future of biotherapeutics.
-
Learn how Pierre Fabre Laboratories streamlined their antibody development with the implementation of a new platform, enabling efficient and multi-parameter stability measurements.
-
See how Cube Biotech and MIT researchers used dynamic light scattering (DLS) and nano differential scanning fluorimetry (nanoDSF) to find the best nanodisc conditions for three membrane proteins.
-
Explore four essential questions to ask yourself when developing a PROTAC molecule to ensure you’re on the right track to protein degradation success.
-
Membrane proteins are vital for drug discovery, but traditional techniques can disrupt their structure. This study showcases a new method that maintains native conformation during analysis.
-
Formulation development is a vital part of the drug development process. Explore key factors to consider in pre-formulation.
-
Review how different excipients stabilize biologics in unique ways and are important considerations in the pre-formulation stage.
-
This article outlines the process of conducting thermal stability experiments and the significance of self-association parameters.
-
Biophysical characterization measurements from nanoDSF, DLS, backreflection, and SLS, are valuable to provide stability attributes of your biologics.
-
Learn how biologics scientists use DLS to get more detailed and reliable insights into their candidates so they de-risk downstream development.
-
To gain insight into your protein’s structure and function, understanding what affects its stability is key. Read this blog to learn about 6 parameters to monitor protein stability.
-
Learn how to apply information from Dynamic Light Scattering (DLS) measurements to support your decision-making process for several experiments of biologics development.
-
To determine colloidal stability of biologics candidates, scientists rely on particle size and dispersity in solution using DLS experiments. Learn how five formulation changes affect the DLS read-out.